Format

Send to

Choose Destination
  • The following term was not found in PubMed: Silva-Novoa.
Int J Clin Pract. 2014 Jan;68(1):28-39. doi: 10.1111/ijcp.12251.

Glycaemic control and implementation of the ADA/EASD-2006 consensus algorithm in type 2 diabetes mellitus patients in primary care in Spain.

Collaborators (283)

García Soidán FJ, Martínez González MM, Garcia ML, Herreros FJ, Ortega Ríos FJ, Iparraguirre ST, Berengué Iglesias MD, Poncelas AR, Pérez JN, Beltran DO, Barbero RA, Vives ML, Álvarez BÁ, Manjavacas CG, Kohan ID, Menendez SA, Prieto Romo JI, Taboada M, Rodriguez Mendez SA, Rodriguez Encinar JR, Barrera FC, Astudillo Martin FJ, Castrillo CG, Lachica LA, Dominguez RQ, Pozo AH, Sangrós González FJ, Blanco AP, Manzano JL, Onieva JR, Navarrete AM, Vicente MS, Rubio LB, Bengoechea PP, de Haro MC, Fernandez MT, Chillida JR, King AP, de MIguel LP, Alonso JJ, Larrégola LS, Rosa CA, Garcia JL, Landeras MT, Frutos MJ, del Barrio EP, Acevedo JR, Arias EA, Martín VR, Sanchez ES, Ramos IA, Molano MM, De la puente JB, Descamps MP, Bou AA, Pastor JC, Garrido Martin JM, Lopez Martinez JA, Bestard PS, Vizcaino JG, Sanmartin Fernandez MD, Nadal Cardona JF, Olle SR, Barriga CL, Pulido ME, Vilaseca EB, Gregorio AP, Martín GA, de la Concepción LV, Pablos MD, Pérez JL, Marcos MJ, Izquierdo MI, Mansino PT, Boronat EF, Rabadan CL, Martínez FJ, Salas IP, Andres AL, Delgado JM, Chicharro LN, Espiñeira MM, Cabrera MJ, Araníbar JA, Gonzalez LC, Dorta IA, Hernández SR, Rivero GE, Goti MC, Martinez AP, Sabio AH, Valverde SQ, Garijo DJ, Valiente MC, Mateos JI, Bermúdez ML, Fernandez MR, Pérez SA, Pérez JJ, Lorenzo FP, Rodriguez MT, Soria MA, Mateo TS, Vidal FP, Lázaro JL, Tavira NA, Placencia EN, Cerdan CC, Palomares JM, Sotos TA, Becerra JA, Torralba TP, Salgado AS, Rangel FG, Moreno RR, Romero MP, Real GC, Moguel EC, Quiles JA, Arnaldos JM, De Tena Frias FJ, Rodríguez AC, Delgado MD, Alvarez JP, Camacho PN, Fortes EA, Cohen VS, Bernabé FJ, Espinosa de los Monteros JA, Martínez AM, Pérez AJ, Tejerina CN, Muñoz MJ, Caro AJ, de la Linde MP, Lopez Aranda JF, Lopez Cruz JA, Bernal MT, Lendinez LC, Madrona TM, Cristobal JM, Villa EG, Segovia JC, Avila MF, Linares CN, Fraile EG, Gimenez MD, Martin JC, Santaella MD, Osorio AJ, Cobos LE, Moreno JC, Gallardo DG, Hernán JC, Lopez FJ, Varillas AT, García AR, Alemany AG, Lopez Perez JJ, Perea AP, Sala ET, Sucarrats LS, Argilagós AV, Muñoz RC, Rel VL, Curbelo AR, Rams FR, Gusta MT, Martínez MD, Gras JF, Farre DP, Girona EM, Salvà ML, Herrero MG, Murua MD, Masllorens IC, Martínez RM, Serra CS, Soler CR, Martinez MJ, Pons RA, Perez JM, Arnauda NB, Mari RR, Nebot SB, Berenguer IP, Navarro MA, Melendez BN, Piña VM, Pérez JS, Vicentecañizares M, Muñoz FA, Sagala MF, Esteban MB, Carbajo MJ, Vallejo EA, Garcua JI, Pelayo TC, Casado IG, Marcos MA, Sastre JJ, Meléndez AJ, Muñoz hernández JG, otero Rodriguez JA, Escarda ME, Ramon EG, López CM, Gomez AF, Solis VG, Diaz RQ, Gonzalez Rodriguez LA, Fernandez MS, Calvo JC, Gonzalez Lorenzo Mdel P, Rodriguez MA, Tobar MT, Dosal CH, González OP, Pesquera AG, Sañudo MP, Fernández JL, Gutiérrez AR, Rodriguez JA, Fernandez JF, Marín jM, Pueyo IM, Egaña AM, Olano MJ, Berrondo MC, Goya LL, Orbegozo JA, Fernández IL, Adan Gil FM, Casado RR, Rodriguez SO, Gil CJ, Belio JF, Viejo MN, Palomar PL, Duarte AV, Viallagrasa SV, Mestre BC, Esteve EL, Cornellana MP, López SG, Tolosa AV, Saló CM, Sánchez FC, Fontanillas ME, Terradas LS, Muñoz JM, Basallote SG, Ruiz SH, Aguilar JL, Ruiz MC, Zamarriego MJ, Rodriguez Me, García JA, Sanchez JC, Ruiz FA, Blanco FJ, Muñoz SM, Chicano JP, Lorente JA, Fajardo FJ, Muñoz EN, Jimenez FS, Fuentes IF, Alba JF, Lorente JL, Jodar FP, Peña MJ, Iglesias FC, Ureta Ide P, Madroñero TL, Aguilera MD, Garcia JJ, González CS, Simon JJ, Garcia MC, Ortega JA, Mainz VU, Atalaya JC.

Author information

1
La Calzada II Health Care Centre, Gijón, Spain.

Abstract

BACKGROUND:

In 2006, the American Diabetes Association and the European Association for the Study of Diabetes established a consensus algorithm (ADA/EASD-2006) for the adjustment of drug therapy for type 2 diabetes mellitus (T2DM).

AIMS:

To study glycaemic control in T2DM patients and the implementation of the ADA/EASD-2006 recommendations in primary care centres in Spain.

METHODS:

Prospective observational study in 1194 patients with T2DM conducted in 250 primary care centres in Spain. Patients were assessed at study inclusion (V0) and at 3 (V1) and 6 months (V2) post baseline. Information was collected at the level of DM control, HbA(1c) < 7% (HbC) and implementation of the ADA/EASD-2006 guidelines.

RESULTS:

Type 2 diabetes mellitus patients (53% women; mean age 64.9 years) had a mean (SD) HbA(1c) 7.8 (1.4)% and HbC 25.2% at baseline, 95% of them were receiving oral antihyperglycaemic agents (AAs) only. At V1, HbA(1c) was 7.3 (1.1)% and HbC was 38.1%; 65.0% of patients were receiving oral AAs, 5.6% insulin and 27.9% oral AAs plus insulin. At V2, HbA(1c) was 7.1 (0.9)% and HbC was 48.0%; 57.1% of patients were receiving oral AAs, 5.0% insulin and 36.9% oral AAs plus insulin. The ADA/EASD-2006 algorithm was adhered to in 33% patients up to study month 3, vs. 17.2% throughout the entire 6-month period.

CONCLUSION:

In patients with T2DM seen in primary care, the HbA1c target was met in 48.0% after adjusting their AAs. However, this is not reflected in greater implementation of the ADA/EASD-2006 guidelines, which are adhered to in only 17%.

PMID:
24341300
DOI:
10.1111/ijcp.12251
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center